To address these limitations, we newly applied PSM to adjust for confounding factors such as age, gender, ECOG-PS, etiology, muscle atrophy, AFP, ALBI score, tumor size, number of treated lesions, and vascular invasion. Here, AFP is linked to neoplasm.